BINV.ST
Price:
$45
Market Cap:
$2.96B
BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, Japan, and internationally. Its lead drug candidate is BI-1206 for the treatment of non-Hodgkin lymphoma and solid tumors. The company also develops tumor associated myeloid cells; cancer-associated regulatory T cells, which modulate the immune system; BT-001 in solid tumors; and BI-1808 and BI-1910, which are anti-TNFR2 antibodies for the treatment of solid tumors and cutaneous T-cell lymphoma. It has a strategic collaboration with Pfizer Inc. for the development of antibodies against tumor-associated ...[Read more]
Industry
Biotechnology
IPO Date
2001-06-12
Stock Exchange
STO
Ticker
BINV.ST
According to BioInvent International AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 13.29. This represents a change of -1.49% compared to the average of 13.49 of the last 4 quarters.
The mean historical Current Ratio of BioInvent International AB (publ) over the last ten years is 8.29. The current 13.29 Current Ratio has changed 15.93% with respect to the historical average. Over the past ten years (40 quarters), BINV.ST's Current Ratio was at its highest in in the June 2021 quarter at 27.99. The Current Ratio was at its lowest in in the March 2016 quarter at 1.97.
Average
8.29
Median
5.00
Minimum
2.13
Maximum
18.98
Discovering the peaks and valleys of BioInvent International AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 253.14%
Maximum Annual Current Ratio = 18.98
Minimum Annual Increase = -35.83%
Minimum Annual Current Ratio = 2.13
Year | Current Ratio | Change |
---|---|---|
2023 | 14.93 | 20.24% |
2022 | 12.41 | -34.60% |
2021 | 18.98 | 31.39% |
2020 | 14.45 | 253.14% |
2019 | 4.09 | 31.00% |
2018 | 3.12 | -17.53% |
2017 | 3.79 | -35.83% |
2016 | 5.90 | 177.65% |
2015 | 2.13 | -31.53% |
2014 | 3.10 | 29.90% |
The current Current Ratio of BioInvent International AB (publ) (BINV.ST) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
15.44
5-year avg
12.97
10-year avg
8.29
BioInvent International AB (publ)’s Current Ratio is greater than Hansa Biopharma AB (publ) (2.45), greater than Saniona AB (publ) (4.24), greater than Active Biotech AB (publ) (0.93), greater than Oncopeptides AB (publ) (3.48), greater than Cantargia AB (publ) (3.67),
Company | Current Ratio | Market cap |
---|---|---|
2.45 | $2.19B | |
4.24 | $355.41M | |
0.93 | $173.85M | |
3.48 | $438.37M | |
3.67 | $547.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioInvent International AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioInvent International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is BioInvent International AB (publ)'s Current Ratio?
How is the Current Ratio calculated for BioInvent International AB (publ) (BINV.ST)?
What is the highest Current Ratio for BioInvent International AB (publ) (BINV.ST)?
What is the 3-year average Current Ratio for BioInvent International AB (publ) (BINV.ST)?
What is the 5-year average Current Ratio for BioInvent International AB (publ) (BINV.ST)?
How does the current Current Ratio for BioInvent International AB (publ) (BINV.ST) compare to its historical average?